openPR Logo
Press release

DBM and Auxiant Team up to Fight Against Rising Medical Costs

10-07-2010 10:51 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: DiaTri LLC

DBM and Auxiant Team up to Fight Against Rising Medical Costs

In the constant fight within the Group Health TPA environment to control the ever-rising costs of medical procedures and to thus stay competitive within an industry that is proving difficult to find ways to retain clients who move partners often, DBM has been successful in contracting with Auxiant to provide an aggressive cost-containment solution for Diagnostic Imaging Studies.

With the increase in costs and utilization of these services, Diagnostic Imaging (CAT Scans, MRIs and PET Scans) now represent upwards of 15+% of the total medical costs for any given employer or group. On average given a set of covered lives, 18% of those lives will have one of these 3 high cost imaging procedures within the next year. Through the implementation of DBM, Auxiant now has the ability to cut nearly 50% of the cost of the expected 16,200 tests per year from their 90,000 covered lives. Through upfront claims analysis, DBM expects average savings per study to be as high as $1,000.00 leaving Auxiant employers with an aggregate, potential savings of $16,200,000.00 per year.

“Cutting medical costs is the key to our success”, said Joe Holt, VP of Sales for Auxiant. “This program will do that for us and offer a 100% ROI because the DBM program does not involve any access or usage fees of any kind. Given the savings potential, the Concierge Service they provide the members and their treating physicians (which is outstanding by the way), and no fees, this was clearly a no-brainer in my mind. We are excited and expect our clients to be very happy with this new program.”

DBM President Scott Fuqua stated: “It is great to see us continuing to move forward within this Group Health TPA market. Our program is such a great fit within that arena so it is great to see someone like Joe quickly recognize the value that the DBM program can bring his company as well as his clients. It is innovative thinking and a lack of fear of change that a group like Auxiant has within its culture and it groups like that that will continue to survive and grow. We are excited to be working with them.”

To learn more about DBMs’ suite of products and services, to receive a Press Kit, or to speak to someone directly to learn how to implement its programs and access it’s over 3900 facilities nationwide for NO FEES, please contact us at 1-800-331-5720.

About DiaTri and DBM:
DiaTri, LLC is the leader in managing and developing diagnostic nuclear medicine networks and cost containment programs, that bring the payor/patient and provider community together in a mutually beneficial relationship. DiaTri, LLC is an investment holding company with three wholly-owned subsidiaries: Diagnostic Benefit Management, LLC (DBM) – National Diagnostic Imaging solutions for the Group Health market with a national radiology network of over 3900 centers in 43 states for scheduling MRIs, CTs, & PET Scans. Advanced Ancillary Services, LLC (AAS) - A proven program for Retrospective Bill Review and Negotiations, Second Opinion Programs for Imaging and Age of Injury Reports. Midwest Diagnostic Management, LLC (MDM) – Diagnostic Imaging Network/Scheduling service for Workers’ Compensation.

About Auxiant:
Auxiant is a Third Party Administrator (TPA) of self-funded benefit plans. Our specialty is customization, technological tools for clients and individuals, and cost-control and health management. We provide administration for over 33,000 employees from our administrative offices in Madison Wisconsin and Cedar Rapids, Iowa. Our Sales offices are in Cedar Rapids, Iowa and Milwaukee, Wisconsin.

DiaTri LLC
19065 Hickory Creek Drive
Mokena, IL 60448

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release DBM and Auxiant Team up to Fight Against Rising Medical Costs here

News-ID: 147134 • Views:

More Releases for DBM

Dibutyl Maleate (DBM) Market Competitive Analysis, Future Prospects and Growth F …
The Dibutyl Maleate (DBM) Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report. The global dibutyl maleate (DBM) market
Global Demineralized Bone Matrix (DBM) Market Overview Report by 2020-2025
Scope of the Report: The global Demineralized Bone Matrix (DBM) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.9%% in the forecast period of 2020 to 2025 and will expected to reach USD 664.5 million by 2025, from USD 616.7 million in 2019. Market segmentation Demineralized Bone Matrix (DBM) market is split by Type and by Application. For the period 2015-2025,
Dead Burned Magnesia (DBM) Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Dead Burned Magnesia (DBM) Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. Dead Burn Magnesia (DBM) is the main raw material for basic refractory products and is widely used in the production of shaped and amorphous refractories. The Global DBM market size was 1537.95 million USD in 2018 and it will be
Demineralized Bone Matrix (DBM) Market Size, Share, Development by 2024
Market Research Report Store offers a latest published report on Demineralized Bone Matrix (DBM) Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Demineralized Bone Matrix (DBM) market will register a 9.3% CAGR in terms of revenue, the global market size will reach US$ 923 million by 2024, from US$ 647.6
Global Dibutyl Maleate (DBM, CAS 105-76-0) Market Outlook 2019-2024
Market Research Report Store offers a latest published report on Dibutyl Maleate Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/592703/global-dibutyl-maleate-dbm-cas-105   The analysts forecast the global dibutyl maleate
Global Demineralized Bone Matrix Dbm Sales Market Industry Trend and Forecast 20 …
This report studies the Demineralized Bone Matrix (DBM) market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Demineralized Bone Matrix (DBM) market by product type and applications/end industries. In the last several years, global market of demineralized bone matrix (DBM) developed rapidly, with an average growth rate